Memantine Add-On Therapy to Clozapine
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2015
Price : $35 *
At a glance
- Drugs Memantine (Primary) ; Clozapine
- Indications Schizophrenia
- Focus Proof of concept; Therapeutic Use
- Acronyms MAC; MAOTC
- 17 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 02 Feb 2015 Planned End Date changed from 17 May 2014 to 16 Sep 2015 as per ISRCTN: Current Controlled Trials.
- 02 Feb 2015 Status changed from completed to active, no longer recruiting ISRCTN: Current Controlled Trials.